Preliminary data indicate that high doses of ribavirin are required to inhibit SARS-CoV-2 in vitro.
Data za awali zinaonyesha kipimo cha kiwango cha juu cha ribavirin ni muhimu kuzuia SARS-CoV-2 katika chombo cha glasi.